Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.7008
H.R.7008: Pre-approval Information Exchange Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 9, 2022
- Latest Major Action March 10, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - March 9, 2022
Bill Summary
Pre-approval Information Exchange Act of 2022 This bill specifies that economic, scientific, or other product support information that is exchanged between drug manufacturers and health care entities (e.g., pharmacy benefit managers) about drug products before regulatory approval is not considered to be misbranded or prohibited premarket promotion if it relates to the product's investigational use and meets other specified criteria. The...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 10, 2022 |
Referred to the Subcommittee on Health.
|
March 9, 2022 |
Referred to the House Committee on Energy and Commerce.
|
March 9, 2022 |
Introduced in the House by Brett Guthrie (R-Ky.) |